Skip to content
Opening soonHORIZON-HLTH-2027-03-TOOL-04HaDEAOne-off

Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis

Using Virtual Human Twins for clinical decision support in prevention and diagnosis.

Horizon Europe research action (RIA) on multiscale and multi-organ models of the human (Virtual Human Twins) that support healthcare professionals in prevention and diagnosis.

Opening soon
197
days until opening
Opens on 3 June 2027
HORIZON-HLTH-2027-03-TOOL-04
View all deadlines
Beta

This grant database is in beta

Until the official launch on 1 January 2027 we are making the final improvements. Our editors check every scheme, but details may still be incomplete or out of date. Check the official publication before you apply.

In brief

What is Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis?

Who
A consortium of at least three independent organisations from three different countries, of which at least one from an EU Member State and the others from Member States or Associated Countries; companies of any size, research organisations, public authorities, foundations and associations can participate, and organisations from the United States can also receive funding. Organisations established in China and high-risk suppliers of mobile network equipment are excluded.
General Annex B (Entities eligible to participate; Entities eligible for funding; Consortium composition); Destination; Specific conditions, Eligibility conditions
What for
A research and innovation action that develops and validates Virtual Human Twins: digital models of an individual patient at multiple scales for integrated clinical decision support in prevention and diagnosis. The aim is personalised prevention and diagnosis with digital twins in healthcare.
Expected Outcome; Scope
What you get
A grant covering 100% of eligible costs; the Commission considers an EU contribution of €10 to 12 million per project appropriate. The indicative budget for the topic is €39.3 million, with 4 projects expected to be funded.
Specific conditions (Expected EU contribution per project, Indicative budget); General Annex G, Funding rates
What you need to do
Submit a proposal in a single stage via the Funding & Tenders Portal from 3 June 2027 until 16 September 2027 (17:00 Brussels time) at the latest, with application form Part A, Part B and, where applicable, an annex on clinical studies. Independent experts evaluate and rank the proposals; results follow around 5 months after the deadline.
Budget overview; Application and evaluation forms; General Annex F

Built from the details on this page, with nothing added by us.

Purpose & impact

Why does this scheme exist?

Personalised prevention and diagnosis with digital twins in healthcare.

01
Patient models for healthcare professionals
Healthcare professionals gain access to multiscale and multi-organ models of individual patients that improve prevention and diagnosis in areas with a high disease burden.
02
Greater knowledge of complex diseases
Healthcare professionals gain greater insight into complex diseases and comorbidity with the help of multiscale and multi-organ models.
03
Better prevention and diagnostics for everyone
Patients with diverse characteristics benefit from improved, integrated and personalised tools for prevention and diagnostics.
04
Integration via Virtual Human Twins
Healthcare professionals and patients benefit from Virtual Human Twin models that integrate other preventive and diagnostic tools and modalities.
Description

About the scheme

Compiled from passages of the scheme's official publication, with nothing added by us.

VHTs are digital representations and in-silico models of an individual’s health and disease state at different levels of anatomy. Multi-scale, multi-organ VHT solutions have a potential for tailored prevention and diagnosis, particularly in areas of high disease burden, and can significantly benefit citizens' health and the efficiency of EU health systems.

Read more

Proposals should take into account the work of projects funded under topic HORIZON-HLTH-2023-TOOL-05-03: “Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management”, which had a predominant focus on disease management, and focus on high-potential multi-disciplinary approaches at greater complexity (multiscale, multiorgan, longitudinal), strengthening their deployment in health and care, including the integration into care pathways and links with other decision support tools.

Am I eligible?

Conditions

Quoted verbatim from the scheme, with the article that sets each condition.

01
To be eligible for funding, applicants must be established in one of the following countries: – the Member States of the European Union, including their outermost regions … – the Overseas Countries and Territories (OCTs) linked to the Member States … – countries associated to Horizon Europe … – the following low- and middle-income countries
02
Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.
03
Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.
04
Legal entities established in China are not eligible to participate in both Research and Innovation Actions (RIAs) and Innovation Actions (IAs) falling under this destination.
05
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
06
If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).
07
Entities that are assessed as high-risk suppliers of mobile network communication equipment (and any entities they own or control) are not eligible to participate as beneficiaries, affiliated entities and associated partners.
All sizes
Micro< 10 FTE
Small< 50 FTE
Medium< 250 FTE
Large≥ 250 FTE
Themes
Onderzoek, ontwikkeling en innovatieGezondheid, zorg en welzijnZorginnovatie en e-health
Project phase
ResearchDevelopment
Funding

What do you get?

100% of your eligible project costs.

Note on the maximum
No binding maximum; the Commission considers an EU contribution of €10 million to €12 million per project appropriate.
€39.3m · Indicative topic budget, 4 projects expected to be funded.
Budget status
Not published by the source
The sources do not say how much budget is left (checked 18 November 2026).
No double funding: an action can receive only one grant from the EU budget (except EU Synergy grants) and the same costs may never be declared under two different EU actions (General Annex G).
Type
Direct grant (non-repayable)
Calendar

Deadlines & cycles

3
JUN
HORIZON-HLTH-2027-03-TOOL-04 opens 3 June 2027
Budget overview
Cycle: Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F). General Annex F, Indicative timetable for evaluation and for signature of the grant agreement
Application

How do you apply?

Pre-registration
Required, before the full application
Required attachments
  • Application form Part A: administrative information on the participants and summarised budget (to be completed online)
  • Application form Part B: technical description of the project (PDF, maximum 40 pages)
  • Clinical studies annex (template in the submission system) for the clinical studies included in the proposal
Procedure
Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Health and Digital Executive Agency (HaDEA).
Eligible costs

What can the money be spent on?

Personnel costs
Materials
Subcontracting
Equipment
Land
Not eligible
Buildings
Not eligible
Overheads
Travel costs
Other costs
Actual costs in accordance with the Horizon Europe Model Grant Agreement (personnel, subcontracting, travel, equipment and other goods and services costs) plus 25% flat-rate indirect costs. Funding rate 100% (General Annex G).
Downloads

Files & forms

Changes

What has changed?

10 November 2026scheme · version 5

Subtitle
Subtitle: ChangedShow
Before

Virtual Human Twins inzetten voor klinische beslissingsondersteuning bij preventie en diagnose.

Now

Using Virtual Human Twins for clinical decision support in prevention and diagnosis.

Description
Description: ChangedShow
Before

Projecten ontwikkelen en valideren Virtual Human Twins: digitale in-silicomodellen van de gezondheid en ziekte van een individu op meerdere anatomische niveaus. De oplossingen bieden geïntegreerde klinische beslissingsondersteuning voor preventie en diagnose, vooral bij aandoeningen met een hoge ziektelast. In de VS gevestigde entiteiten kunnen EU-financiering ontvangen.

Now

Projects develop and validate Virtual Human Twins: digital in-silico models of an individual's health and disease across multiple anatomical levels. The solutions provide integrated clinical decision support for prevention and diagnosis, especially for conditions with a high disease burden. Entities established in the US can receive EU funding.

Short description
Short description: ChangedShow
Before

Horizon Europe-onderzoeksactie (RIA) naar multischaal- en multi-orgaanmodellen van de mens (Virtual Human Twins) die zorgprofessionals ondersteunen bij preventie en diagnose.

Now

Horizon Europe research action (RIA) on multiscale and multi-organ models of the human (Virtual Human Twins) that support healthcare professionals in prevention and diagnosis.

Cycle
Cycle: ChangedShow
Before

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Now

Evaluation results around 5 months after the deadline; signature of the grant agreement around 8 months after the deadline (General Annex F).

Note on the total budget
Note on the total budget: ChangedShow
Before

Indicatief topicbudget, naar verwachting 4 projecten.

Now

Indicative topic budget, 4 projects expected to be funded.

Note on the maximum
Note on the maximum: ChangedShow
Before

Geen bindend maximum; de Commissie acht € 10 mln tot € 12 mln EU-bijdrage per project passend.

Now

No binding maximum; the Commission considers an EU contribution of €10 million to €12 million per project appropriate.

Cumulation
Cumulation: ChangedShow
Before

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Now

No double funding: an action can receive only one grant from the EU budget (except EU Synergy grants) and the same costs may never be declared under two different EU actions (General Annex G).

Search engine title
Virtual Human Twins voor preventie en diagnose becomes Virtual Human Twins for prevention and diagnosis
Search engine description
Search engine description: ChangedShow
Before

Horizon Europe-onderzoeksactie naar Virtual Human Twins voor klinische beslissingsondersteuning; € 10-12 mln EU-bijdrage per project.

Now

Horizon Europe research action on Virtual Human Twins for clinical decision support; €10-12 million EU contribution per project.

Keywords
Cluster 1 Health, diagnostiek, Horizon Europe, HORIZON-HLTH-2027-03-TOOL-04, klinische beslisondersteuning, preventie, virtuele menselijke tweeling becomes clinical decision support, Cluster 1 Health, diagnostics, Horizon Europe, HORIZON-HLTH-2027-03-TOOL-04, prevention, virtual human twin
Language
Dutch (Netherlands) becomes British English
Required attachments
Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 40 pagina's); Bijlage klinische studies (template in het indieningssysteem) voor de klinische studies die het voorstel omvat becomes Application form Part A: administrative information on the participants and summarised budget (to be completed online); Application form Part B: technical description of the project (PDF, maximum 40 pages); Clinical studies annex (template in the submission system) for the clinical studies included in the proposal
Procedure
Procedure: ChangedShow
Before

Aanvragen via het Funding & Tenders Portal met een EU Login en een PIC-nummer; single-stage; deadline 17:00 uur Brusselse tijd; beheerd door European Health and Digital Executive Agency (HaDEA).

Now

Apply via the Funding & Tenders Portal with an EU Login and a PIC number; single-stage; deadline 17:00 Brussels time; managed by the European Health and Digital Executive Agency (HaDEA).

Notes per cost type
Notes per cost type: ChangedShow
Before

Other costs: Werkelijke kosten volgens de Horizon Europe-modelsubsidieovereenkomst (personeel, onderaanneming, reis-, apparatuur- en overige goederen- en dienstenkosten) plus 25% forfaitaire indirecte kosten. Financieringspercentage 100% (General Annex G).

Now

Other costs: Actual costs in accordance with the Horizon Europe Model Grant Agreement (personnel, subcontracting, travel, equipment and other goods and services costs) plus 25% flat-rate indirect costs. Funding rate 100% (General Annex G).

Why this scheme
Why this scheme: ChangedShow
Before

Gepersonaliseerde preventie en diagnose met digitale tweelingen in de zorg.

Now

Personalised prevention and diagnosis with digital twins in healthcare.

In brief
In brief: ChangedShow
Before

Who: Een consortium van ten minste drie onafhankelijke organisaties uit drie verschillende landen, waarvan minstens één uit een EU-lidstaat en de andere uit lidstaten of geassocieerde landen; bedrijven van elke omvang, onderzoeksinstellingen, overheden, stichtingen en verenigingen kunnen deelnemen, en ook organisaties uit de Verenigde Staten kunnen financiering krijgen. In China gevestigde organisaties en risicoleveranciers van mobiele netwerkapparatuur zijn uitgesloten.

What for: Een onderzoeks- en innovatieactie die Virtual Human Twins ontwikkelt en valideert: digitale modellen van een individuele patiënt op meerdere schaalniveaus voor geïntegreerde klinische beslissingsondersteuning bij preventie en diagnose. Het doel is gepersonaliseerde preventie en diagnose met digitale tweelingen in de zorg.

What you get: Een subsidie van 100% van de subsidiabele kosten; de Commissie acht een EU-bijdrage van € 10 tot 12 miljoen per project passend. Het indicatieve budget voor het topic is € 39,3 miljoen, naar verwachting voor 4 projecten.

What you need to do: Dien vanaf 3 juni 2027 tot uiterlijk 16 september 2027 (17:00 uur Brusselse tijd) in één ronde een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A, deel B en zo nodig een bijlage over klinische studies. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt rond 5 maanden na de deadline.

Now

Who: A consortium of at least three independent organisations from three different countries, of which at least one from an EU Member State and the others from Member States or Associated Countries; companies of any size, research organisations, public authorities, foundations and associations can participate, and organisations from the United States can also receive funding. Organisations established in China and high-risk suppliers of mobile network equipment are excluded.

What for: A research and innovation action that develops and validates Virtual Human Twins: digital models of an individual patient at multiple scales for integrated clinical decision support in prevention and diagnosis. The aim is personalised prevention and diagnosis with digital twins in healthcare.

What you get: A grant covering 100% of eligible costs; the Commission considers an EU contribution of €10 to 12 million per project appropriate. The indicative budget for the topic is €39.3 million, with 4 projects expected to be funded.

What you need to do: Submit a proposal in a single stage via the Funding & Tenders Portal from 3 June 2027 until 16 September 2027 (17:00 Brussels time) at the latest, with application form Part A, Part B and, where applicable, an annex on clinical studies. Independent experts evaluate and rank the proposals; results follow around 5 months after the deadline.

Goals
Goals: 4 removed, 4 newShow
Removed

Patiëntmodellen voor zorgprofessionals Zorgprofessionals krijgen toegang tot multischaal- en multiorgaanmodellen van individuele patiënten die preventie en diagnose in gebieden met een hoge ziektelast verbeteren.

Meer kennis van complexe ziekten Zorgprofessionals krijgen meer inzicht in complexe ziekten en comorbiditeit met behulp van multischaal- en multiorgaanmodellen.

Betere preventie en diagnostiek voor iedereen Patiënten met uiteenlopende kenmerken profiteren van verbeterde, geïntegreerde en gepersonaliseerde instrumenten voor preventie en diagnostiek.

Integratie via Virtual Human Twins Zorgprofessionals en patiënten profiteren van Virtual Human Twin-modellen waarin andere preventieve en diagnostische instrumenten en modaliteiten worden geïntegreerd.

New

Patient models for healthcare professionals Healthcare professionals gain access to multiscale and multi-organ models of individual patients that improve prevention and diagnosis in areas with a high disease burden.

Greater knowledge of complex diseases Healthcare professionals gain greater insight into complex diseases and comorbidity with the help of multiscale and multi-organ models.

Better prevention and diagnostics for everyone Patients with diverse characteristics benefit from improved, integrated and personalised tools for prevention and diagnostics.

Integration via Virtual Human Twins Healthcare professionals and patients benefit from Virtual Human Twin models that integrate other preventive and diagnostic tools and modalities.

Show 4 earlier versions

19 October 2026scheme · version 4

Conditions
Conditions: 2 removed, 7 newShow
Removed

Consortium van minimaal 3 partijen Drie onafhankelijke juridische entiteiten uit drie verschillende EU-lidstaten of geassocieerde landen, waarvan minimaal één uit een lidstaat (General Annex B).

Entiteiten uit de Verenigde Staten komen in aanmerking In de VS gevestigde juridische entiteiten kunnen EU-financiering ontvangen, als erkenning van de openstelling van NIH-programma's voor Europese onderzoekers.

New

To be eligible for funding, applicants must be established in one of the following countries: – the Member States of the European Union, including their outermost regions … – the Overseas Countries and Territories (OCTs) linked to the Member States … – countries associated to Horizon Europe … – the following low- and middle-income countries

Unless otherwise provided for in the specific call/topic conditions, only legal entities forming a consortium are eligible to participate in actions provided that the consortium includes, as beneficiaries, three legal entities independent from each other and each established in a different country as follows: – at least one independent legal entity established in a Member State; and – at least two other independent legal entities, each established in different Member States or Associated Countries.

Applications will only be considered eligible if their content corresponds, wholly or in part, to the topic description for which it is submitted.

Legal entities established in China are not eligible to participate in both Research and Innovation Actions (RIAs) and Innovation Actions (IAs) falling under this destination.

In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.

If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).

Entities that are assessed as high-risk suppliers of mobile network communication equipment (and any entities they own or control) are not eligible to participate as beneficiaries, affiliated entities and associated partners.

In brief
In brief: AddedShow
Now

Who: Een consortium van ten minste drie onafhankelijke organisaties uit drie verschillende landen, waarvan minstens één uit een EU-lidstaat en de andere uit lidstaten of geassocieerde landen; bedrijven van elke omvang, onderzoeksinstellingen, overheden, stichtingen en verenigingen kunnen deelnemen, en ook organisaties uit de Verenigde Staten kunnen financiering krijgen. In China gevestigde organisaties en risicoleveranciers van mobiele netwerkapparatuur zijn uitgesloten.

What for: Een onderzoeks- en innovatieactie die Virtual Human Twins ontwikkelt en valideert: digitale modellen van een individuele patiënt op meerdere schaalniveaus voor geïntegreerde klinische beslissingsondersteuning bij preventie en diagnose. Het doel is gepersonaliseerde preventie en diagnose met digitale tweelingen in de zorg.

What you get: Een subsidie van 100% van de subsidiabele kosten; de Commissie acht een EU-bijdrage van € 10 tot 12 miljoen per project passend. Het indicatieve budget voor het topic is € 39,3 miljoen, naar verwachting voor 4 projecten.

What you need to do: Dien vanaf 3 juni 2027 tot uiterlijk 16 september 2027 (17:00 uur Brusselse tijd) in één ronde een voorstel in via het Funding & Tenders Portal, met aanvraagformulier deel A, deel B en zo nodig een bijlage over klinische studies. Onafhankelijke experts beoordelen en rangschikken de voorstellen; de uitslag volgt rond 5 maanden na de deadline.

18 October 2026scheme · version 3

About the scheme
About the scheme: AddedShow
Now

VHTs are digital representations and in-silico models of an individual’s health and disease state at different levels of anatomy. Multi-scale, multi-organ VHT solutions have a potential for tailored prevention and diagnosis, particularly in areas of high disease burden, and can significantly benefit citizens' health and the efficiency of EU health systems. Proposals should take into account the work of projects funded under topic HORIZON-HLTH-2023-TOOL-05-03: “Integrated, multi-scale computational models of patient patho-physiology (‘virtual twins’) for personalised disease management”, which had a predominant focus on disease management, and focus on high-potential multi-disciplinary approaches at greater complexity (multiscale, multiorgan, longitudinal), strengthening their deployment in health and care, including the integration into care pathways and links with other decision support tools.

16 October 2026scheme · version 2

Cycle
Cycle: AddedShow
Now

Uitslag van de evaluatie rond 5 maanden na de deadline; ondertekening van de subsidieovereenkomst rond 8 maanden na de deadline (General Annex F).

Cumulation
Cumulation: AddedShow
Now

Geen dubbele financiering: een actie kan maar één subsidie uit de EU-begroting krijgen (behalve EU Synergy grants) en dezelfde kosten mogen nooit bij twee verschillende EU-acties worden gedeclareerd (General Annex G).

Keywords
Added: Cluster 1 Health, diagnostiek, Horizon Europe, HORIZON-HLTH-2027-03-TOOL-04, klinische beslisondersteuning, preventie, virtuele menselijke tweeling
Required attachments
Added: Aanvraagformulier deel A: administratieve gegevens van de deelnemers en samengevatte begroting (online in te vullen); Aanvraagformulier deel B: technische beschrijving van het project (pdf, maximaal 40 pagina's); Bijlage klinische studies (template in het indieningssysteem) voor de klinische studies die het voorstel omvat
Goals
Goals: 4 newShow
New

Patiëntmodellen voor zorgprofessionals Zorgprofessionals krijgen toegang tot multischaal- en multiorgaanmodellen van individuele patiënten die preventie en diagnose in gebieden met een hoge ziektelast verbeteren.

Meer kennis van complexe ziekten Zorgprofessionals krijgen meer inzicht in complexe ziekten en comorbiditeit met behulp van multischaal- en multiorgaanmodellen.

Betere preventie en diagnostiek voor iedereen Patiënten met uiteenlopende kenmerken profiteren van verbeterde, geïntegreerde en gepersonaliseerde instrumenten voor preventie en diagnostiek.

Integratie via Virtual Human Twins Zorgprofessionals en patiënten profiteren van Virtual Human Twin-modellen waarin andere preventieve en diagnostische instrumenten en modaliteiten worden geïntegreerd.

8 October 2026scheme · version 1 · first publication

Source

Contact & source

Funding body
European Health and Digital Executive Agency
Last verified
12 November 2026 by the Twin editors
Start your application

Start your HORIZON-HLTH-2027-03-TOOL-04 application
in Twin.

Twin helps you write your application, based on the scheme and your own project documents. You stay in control of every text.